MyFinsight
Home
Blog
About
Cash and cash
equivalents
$237,366K
Marketable securities
$220,094K
Prepaid expenses and
other current assets
$6,538K
Total current assets
$463,998K
Other non-current
assets
$2,286K
Operating right-of-use
assets
$901K
Property and equipment,
net
$596K
Total assets
$467,781K
Total liabilities,
convertible preference...
$467,781K
Total stockholders'
equity (deficit)
$454,271K
Total liabilities
$13,510K
Accumulated deficit
-$228,695K
Accumulated other
comprehensive (loss) income
-$2,748K
Additional paid in capital
$685,709K
Total current
liabilities
$12,944K
Operating lease
liabilities, net of current...
$566K
Stockholders' deficit-Common
Stock
$5K
Accrued expenses and
other current...
$6,252K
Accounts payable
$6,232K
Operating lease
liabilities
$460K
Back
Back
Balance Sheet
Hemab Therapeutics Holdings, Inc. (COAG)
Hemab Therapeutics Holdings, Inc. (COAG)
source: myfinsight.com